Literature DB >> 16672363

Structure of the ternary signaling complex of a TGF-beta superfamily member.

George P Allendorph1, Wylie W Vale, Senyon Choe.   

Abstract

The crystal structure of the complete signaling complex formed between bone morphogenetic protein 2 (BMP-2) and the extracellular domains (ECDs) of its type I receptor [bone morphogenetic protein receptor type Ia (BMPR-Ia)-ECD] and its type II receptor [activin receptor type II (ActRII)-ECD] shows two fundamental structural constraints for receptor assembly. First, the homodimeric BMP-2 ligand assembles two pairs of each receptor symmetrically, where each of the receptor ECDs does not make physical contact. Therefore, conformational communication between receptor ECDs, if any, should be propagated through the central ligand. Second, the type I and II receptor interfaces of the complex, when compared with those of binary complexes such as BMP-2/BMPR Ia-ECD, BMP-7/ActRII-ECD, and activin/ActRIIb-ECD, respectively, show there are common sets of positions repeatedly used by both ligands and receptors. Therefore, specificity-determining amino acid differences at the receptor interfaces should also account for the disparity in affinity of individual receptors for different ligand subunits. We find that a specific mutation to BMP-2 increases its affinity to ActRII-ECD by 5-fold. These results together establish that the specific signaling output is largely determined by two variables, the ligand-receptor pair identity and the mode of cooperative assembly of relevant receptors governed by the ligand flexibility in a membrane-restricted manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672363      PMCID: PMC1456805          DOI: 10.1073/pnas.0602558103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules.

Authors:  U A Vitt; S Y Hsu; A J Hsueh
Journal:  Mol Endocrinol       Date:  2001-05

2.  Identification of a binding site on the type II activin receptor for activin and inhibin.

Authors:  P C Gray; J Greenwald; A L Blount; K S Kunitake; C J Donaldson; S Choe; W Vale
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 4.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

5.  Characterization of the extracellular ligand-binding domain of the type II activin receptor.

Authors:  J Greenwald; V Le; A Corrigan; W Fischer; E Komives; W Vale; S Choe
Journal:  Biochemistry       Date:  1998-11-24       Impact factor: 3.162

6.  Biochemical and biophysical characterization of refolded Drosophila DPP, a homolog of bone morphogenetic proteins 2 and 4.

Authors:  J Groppe; K Rumpel; A N Economides; N Stahl; W Sebald; M Affolter
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

7.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo.

Authors:  D I Israel; J Nove; K M Kerns; R J Kaufman; V Rosen; K A Cox; J M Wozney
Journal:  Growth Factors       Date:  1996       Impact factor: 2.511

Review 8.  Specificity and versatility in tgf-beta signaling through Smads.

Authors:  Xin-Hua Feng; Rik Derynck
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 9.  Signal transduction by members of the transforming growth factor-beta superfamily.

Authors:  L Attisano; J L Wrana
Journal:  Cytokine Growth Factor Rev       Date:  1996-12       Impact factor: 7.638

10.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis.

Authors:  Cecil Chen; Krzysztof J Grzegorzewski; Steve Barash; Qinghai Zhao; Helmut Schneider; Qi Wang; Mallika Singh; Laurie Pukac; Adam C Bell; Roxanne Duan; Tim Coleman; Alokesh Duttaroy; Susan Cheng; Jon Hirsch; Linyi Zhang; Yanick Lazard; Carrie Fischer; Melisa Carey Barber; Zhi-Dong Ma; Ya-Qin Zhang; Peter Reavey; Lilin Zhong; Baiqin Teng; Indra Sanyal; Steve M Ruben; Olivier Blondel; Charles E Birse
Journal:  Nat Biotechnol       Date:  2003-02-24       Impact factor: 54.908

View more
  104 in total

1.  ZAS3 accentuates transforming growth factor β signaling in epithelial cells.

Authors:  Adam J Yakovich; Bo Jiang; Carl E Allen; Jianguo Du; Lai-Chu Wu; John A Barnard
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

2.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.

Authors:  Michael J Isaacs; Yasuhiko Kawakami; George P Allendorph; Byung-Hak Yoon; Juan Carlos Izpisua Belmonte; Senyon Choe
Journal:  Mol Endocrinol       Date:  2010-05-19

3.  A variant of human growth differentiation factor-9 that improves oocyte developmental competence.

Authors:  William A Stocker; Kelly L Walton; Dulama Richani; Karen L Chan; Kiri H Beilby; Bethany J Finger; Mark P Green; Robert B Gilchrist; Craig A Harrison
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

4.  Peptide ligands that use a novel binding site to target both TGF-β receptors.

Authors:  Lingyin Li; Brendan P Orner; Tao Huang; Andrew P Hinck; Laura L Kiessling
Journal:  Mol Biosyst       Date:  2010-10-04

5.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

6.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

7.  Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression.

Authors:  Moataz Elkasrawy; Sadanand Fulzele; Matthew Bowser; Karl Wenger; Mark Hamrick
Journal:  Growth Factors       Date:  2011-07-15       Impact factor: 2.511

8.  N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.

Authors:  Jonathan W Lowery; Jose M Amich; Alex Andonian; Vicki Rosen
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

9.  Designer nodal/BMP2 chimeras mimic nodal signaling, promote chondrogenesis, and reveal a BMP2-like structure.

Authors:  Luis Esquivies; Alissa Blackler; Macarena Peran; Concepcion Rodriguez-Esteban; Juan Carlos Izpisua Belmonte; Evan Booker; Peter C Gray; Chihoon Ahn; Witek Kwiatkowski; Senyon Choe
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 10.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.